Apnimed is a series c plus startup based in United States. 1 investor tracked.
Apnimed is a company headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
A clinical-stage pharmaceutical company developing novel oral pharmacologic treatments for Obstructive Sleep Apnea (OSA) and related disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.